Vincent Van Pesch
Vincent Van Pesch publishes mostly in Pathology and Forensic Medicine, Neurology and Rheumatology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Amyotrophic Lateral Sclerosis Research.
- World rank
- #309,761 of 7,710,434 ranked researchers
- Rank in Belgium
- #2,459 of 67,186
- Works
- 322
- Citations
- 11k
- Citations per work
- 33.6
What does Vincent Van Pesch research?
Vincent Van Pesch's work is mostly in Medicine (51%), Immunology and Microbiology (5%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16551.1%
- Medicine16551.1%
- Everything else12940.1%
- Life Sciences288.8%
- 1Pathology and Forensic Medicine25% of their works
- 2Neurology15% of their works
- 3Rheumatology6% of their works
- 4Oncology6% of their works
- 5Immunology5% of their works
- 6Molecular Biology4% of their works
Research topics
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Amyotrophic Lateral Sclerosis Research
- Polyomavirus and related diseases
- Rheumatoid Arthritis Research and Therapies
- Systemic Sclerosis and Related Diseases
- Systemic Lupus Erythematosus Research
- Autoimmune Neurological Disorders and Treatments
Which keywords describe Vincent Van Pesch's research?
The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Autoantibodies, Treatment, Neurological Disorders and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
- Anti-NMDA Receptor Encephalitis
- Antiphospholipid Syndrome
- Fibrosis
- Inflammation
- Merkel Cell Carcinoma
- FUS/TLS
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Treatment
- Neuromyelitis Optica
- Diagnostic Criteria
- Cognitive Impairment
- Multiple Sclerosis
- Autoantibodies
- Neurological Disorders
- Guillain-Barré Syndrome
- TDP-43
- Polyomavirus
- Rheumatoid Arthritis
- Systemic Sclerosis
- Systemic Lupus Erythematosus
- Paraneoplastic Syndromes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Cognitive Impairment2042 topics
- Diagnostic Criteria2042 topics
- Multiple Sclerosis1881 topic
- Neuromyelitis Optica1881 topic
- Autoantibodies804 topics
- Treatment772 topics
- Neurological Disorders732 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy571 topic
- Guillain-Barré Syndrome571 topic
- FUS/TLS301 topic
- TDP-43301 topic
- Merkel Cell Carcinoma291 topic
- Polyomavirus291 topic
- Inflammation261 topic
- Rheumatoid Arthritis261 topic
- Fibrosis201 topic
- Systemic Sclerosis201 topic
- Antiphospholipid Syndrome181 topic
- Systemic Lupus Erythematosus181 topic
- Anti-NMDA Receptor Encephalitis161 topic
- Paraneoplastic Syndromes161 topic
Where does Vincent Van Pesch work?
Vincent Van Pesch's main affiliation in the publication record is Cliniques Universitaires Saint-Luc, Belgium.
How many publications and citations does Vincent Van Pesch have?
OpenAlex counts 322 works and 10,816 citations for Vincent Van Pesch, an h-index of 53, ranking #309,761 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Vincent Van Pesch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.